181 related articles for article (PubMed ID: 30550372)
1. Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry List.
Brauer ER; Long EF; Melnikow J; Ravdin PM; Ganz PA
J Oncol Pract; 2019 Feb; 15(2):e98-e109. PubMed ID: 30550372
[TBL] [Abstract][Full Text] [Related]
2. A mixed method study of medical oncologists' perceived barriers and motivators to addressing long-term effects in breast cancer survivors.
Fauer AJ; Ganz PA; Brauer ER
Breast Cancer Res Treat; 2022 Aug; 194(3):699-707. PubMed ID: 35767127
[TBL] [Abstract][Full Text] [Related]
3. Perspectives and attitudes on the use of adjuvant chemotherapy and trastuzumab in older adults with HER-2+ breast cancer: a survey of oncologists.
Hurria A; Wong FL; Pal S; Chung CT; Bhatia S; Mortimer J; Somlo G; Hurvitz S; Villaluna D; Naeim A
Oncologist; 2009 Sep; 14(9):883-90. PubMed ID: 19726455
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
5. Medical Oncologists' Perspectives on How the Results of the IDEA Collaboration Impact the Adjuvant Treatment of Stage III Colon Cancer.
Yu IS; Pereira AAL; Lee M; Korphaisarn K; Marshall J; Segelov E; O'Callaghan C; Lim HJ; Kopetz S; Loree JM
Oncologist; 2020 Mar; 25(3):229-234. PubMed ID: 32162828
[TBL] [Abstract][Full Text] [Related]
6. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
[TBL] [Abstract][Full Text] [Related]
7. Risk estimations and treatment decisions in early stage breast cancer: agreement among oncologists and the impact of the 70-gene signature.
Drukker CA; van den Hout HC; Sonke GS; Brain E; Bonnefoi H; Cardoso F; Goldhirsch A; Harbeck N; Honkoop AH; Koornstra RH; van Laarhoven HW; Portielje JE; Schneeweiss A; Smorenburg CH; Stouthard J; Linn SC; Schmidt MK
Eur J Cancer; 2014 Apr; 50(6):1045-54. PubMed ID: 24529927
[TBL] [Abstract][Full Text] [Related]
8. Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.
Naeim A; Wong FL; Pal SK; Hurria A
Clin Breast Cancer; 2010 Apr; 10(2):136-43. PubMed ID: 20353934
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
[TBL] [Abstract][Full Text] [Related]
10. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
11. Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up.
Neuman HB; Steffens NM; Jacobson N; Tevaarwerk A; Anderson B; Wilke LG; Greenberg CC
Ann Surg Oncol; 2016 Mar; 23(3):708-14. PubMed ID: 26474556
[TBL] [Abstract][Full Text] [Related]
12. How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.
Moth EB; Kiely BE; Naganathan V; Martin A; Blinman P
Support Care Cancer; 2018 Feb; 26(2):451-460. PubMed ID: 28776149
[TBL] [Abstract][Full Text] [Related]
13. Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists' clinical deliberation.
Otte I; Salloch S; Reinacher-Schick A; Vollmann J
BMC Cancer; 2017 Nov; 17(1):780. PubMed ID: 29162047
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity.
Rocque G; Onitilo A; Engel J; Pettke E; Boshoven A; Kim K; Rishi S; Waack B; Wisinski KB; Tevaarwerk A; Burkard ME
Breast Cancer Res Treat; 2012 Jan; 131(2):713-21. PubMed ID: 22065290
[TBL] [Abstract][Full Text] [Related]
15. International Survey of Pediatric Oncologists' Beliefs and Communication Practices Regarding Symptom Self-Monitoring by Childhood Cancer Survivors.
Webster SN; Spunt SL; Cunningham SJ; Wakefield CE; Smith SM; Alberts NM; Palesh O; Simons LE; Heathcote LC
JCO Oncol Pract; 2023 May; 19(5):e650-e659. PubMed ID: 36800566
[TBL] [Abstract][Full Text] [Related]
16. Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors.
Potosky AL; Han PK; Rowland J; Klabunde CN; Smith T; Aziz N; Earle C; Ayanian JZ; Ganz PA; Stefanek M
J Gen Intern Med; 2011 Dec; 26(12):1403-10. PubMed ID: 21785923
[TBL] [Abstract][Full Text] [Related]
17. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
[TBL] [Abstract][Full Text] [Related]
18. Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.
Davidson B; Vogel V; Wickerham L
J Support Oncol; 2007 Mar; 5(3):139-43. PubMed ID: 17410813
[TBL] [Abstract][Full Text] [Related]
19. Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.
Levine MN; Julian JA; Bedard PL; Eisen A; Trudeau ME; Higgins B; Bordeleau L; Pritchard KI
J Clin Oncol; 2016 Apr; 34(10):1065-71. PubMed ID: 26598746
[TBL] [Abstract][Full Text] [Related]
20. Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work.
Falandry C; Krakowski I; Curé H; Carola E; Soubeyran P; Guérin O; Gaudin H; Freyer G
Breast Cancer Res Treat; 2018 Apr; 168(2):433-441. PubMed ID: 29243107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
